but states that Windstream could rise higher based on an increase in its sales of its broadband bundles, a sharp recovery in the economy and future mergers and acquisitions in the industry. Let us not forget that WIN beat earnings estimates and generated $1,418.6 million in the first quarter.
more than anyone imagines. One would do well to dig through the last 6 earnings reports as presented on the SEC site.
1,116,268 shares and 223,498 shares respectively. They have not sold one share this year. One would assume that they and other insiders are putting their money where the truth lies.
The hidden value of GE is close to $40 a share.
S&P CAPITAL IQ MAINTAINS BUY RECOMMENDATION ON SHARES OF WINDSTREAM HOLDINGS
10:48a ET February 24, 2015 (S&P Capital IQ) Print
We cut our '15 operating EPS estimate to $0.14 from $0.27 and initiate '16's at $0.20. We reduce our 12-month target price by $1 to $10, on an enterprise value-to-EBITDA near peers. WIN posts Q4 operating EPS of $0.03 vs. $0.09, missing our $0.06 estimate, but matching the Capital IQ consensus view. Sales fell 3%, near expectations, hurt by lower carrier and wholesale revenue. We see higher enterprise, consumer and small business sales, but anticipate declines in the carrier business. We see muted near term growth but positively view WIN's REIT spin-off, expected to close in Q2.
My source is a news item from Fidelity.
Thomson Reuters/Verus upgrades FIFTH STREET FINANCE CORPORATION from HOLD to BUY.
BY Investars Analyst Actions - public
— 11:10 AM ET 12/29/2014
On December 29, 2014 Thomson Reuters/Verus upgraded FIFTH STREET FINANCE CORPORATION ( FSC ) from HOLD to BUY.
from HOLD to BUY.
We believe the shares trading at 13.4X our for-
ward 12-months EPS estimate of $2.24, below
peers, are attractively valued in spite of our
view of near-term declining sales and flat earn-
ings growth. But we believe new Treasury De-
partment rules make tax inversion deals less fi-
nancially attractive, thus decreasing the likeli-
hood of PFE pursuing a mega deal for tax rea-
sons instead of a strategic rationale. We are
encouraged by PFE's increased and sizable
share buyback program and expect an increase
to its dividends in Q1 15. We think PFE has a de-
cent pipeline, including palbociclib to treat
breast cancer and bococizumab for the reduc-
tion of LDL cholesterol, currently in Phase III tri-
als. PFE filed an NDA for palbociclib and was
granted a priority review with an April 13, 2015,
PDUFA date. We believe palbociclib could
reach blockbuster sales of $1 billion in 2 years.
"...Pengrowth is in a position to sustain lower crude prices in the coming years. The company has hedged 63% of its crude oil production for 2015 and 33% for 2016 at nearly $83 a barrel. This should protect the company's cash flows even if crude remains around $80 a barrel or lower..."
"... Pengrowth will start producing oil from the first phase of its flagship Lindbergh heavy oil project in January... The project underpins the company's future production and cash flow growth. Lindbergh not only has higher quality of oil compared with similar projects, but also has significantly lower supply costs, making it attractive even if oil prices hover around $70 a barrel in 2015. "
"... oil from Lindbergh would cost slightly more than $50 a barrel. On the other hand, the average cost of other oil sands and shale oil projects is more than $70 a barrel. "
"With gradual ramp ups and contribution from Lindbergh's second phase, the company's total liquids output could increase to more than 51,000 barrels a day by the end of 2016, according to Credit Suisse estimates. "